BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6800754)

  • 1. [Suppressive treatment of normothyroid female goitre patients with reference to patient compliance (author's transl)].
    Kipnowski J; Klingmüller D
    Dtsch Med Wochenschr; 1982 Mar; 107(11):406-10. PubMed ID: 6800754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Standardisation of TRH test for the exact determination of thyroxine treatment (author's transl)].
    Hesch RD; LeBlanc S; von zur Mühlen A
    Dtsch Med Wochenschr; 1981 Jan; 106(5):146-9. PubMed ID: 6781851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of the optimal L-thyroxine dosage for treating nontoxic goiter].
    Biersack HJ; Albrecht W; Oehr P; Rasche A; Winkler C
    Dtsch Med Wochenschr; 1983 Aug; 108(34):1269-73. PubMed ID: 6411440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
    Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sonographic volumetry of the thyroid gland in the control o thyroxin and iodide treatment of non-toxic goiter].
    Olbricht T; Hoff HG; Benker G; Wagner R; Reinwein D
    Dtsch Med Wochenschr; 1985 May; 110(22):863-6. PubMed ID: 3888591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thyroxine in the treatment of euthyroid goiter and the prevention of goiter recurrence].
    Goebel R; Leb G; Pohl P; Haralambus I; Warnkross H
    Acta Med Austriaca; 1976; 3(3):78-80. PubMed ID: 826506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of goiter treatment with L-thyroxine in patients over 40].
    Wollmann B; Meller J; Hüfner M; Becker W
    Nuklearmedizin; 1998 Jan; 37(1):41-4. PubMed ID: 9467169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.
    De Rosa G; Testa A; Maussier ML; Callà C; Astazi P; Albanese C
    Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thyroxine vs iodine and thyroxine. Comparison of the TSH suppression test].
    Kahaly G; Mihaljevic V; Beyer J; Krause U
    Schweiz Med Wochenschr; 1989 Jan; 119(2):59-64. PubMed ID: 2492674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioimmuno-assay of TSH before and after TRH in 350 patients with previous resection of euthyroid goiter (author's transl)].
    Hör G; Kohlhoff U; Bottermann P; Nitz D; Schmid L; Langhammer H; Pabst HW
    Med Klin; 1978 Jun; 73(25):945-50. PubMed ID: 96322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous pituitary-thyroid function after surgical treatment of nontoxic goitre. A controlled long-term study.
    Aagaard J; Blichert-Toft M; Axelsson CK; Christiansen C
    Acta Chir Scand; 1984; 150(2):123-7. PubMed ID: 6426224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of endemic goitre: controlled study on the effect of iodine and thyroxine.
    Hintze G; Emrich D; Köbberling J
    Horm Metab Res; 1985 Jul; 17(7):362-5. PubMed ID: 4029877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of endemic goitre with iodine and thyroid hormones, alone or in combination. (Preliminary report).
    Koutras DA; Karaiskos KS; Piperingos GD; Kitsopanides J; Boukis MA; Makriyannis D; Souvatzoglou A; Sfontouris J; Evangelopoulou K; Moulopoulos SD
    Endocrinol Exp; 1986 Mar; 20(1):57-65. PubMed ID: 3486112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-toxic nodular goiter: treatment and follow-up].
    Mereu P; Scala M; Schenone F; Schenone G; Comandini D; Gipponi M; Margarino G
    Acta Otorhinolaryngol Ital; 1995 Aug; 15(4):301-4. PubMed ID: 8928662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the clinically significant TSH response to TRH in patients with nodular goitre.
    Kirkegaard C; Bregengård C
    Horm Metab Res; 1988 Jun; 20(6):357-9. PubMed ID: 3138170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders of thyroid function and sterility in the woman].
    Bals-Pratsch M; Schober O; Hanker JP; de Geyter C; Schneider HP
    Zentralbl Gynakol; 1993; 115(1):18-23. PubMed ID: 8438626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Weight changes under thyroxine substitution for euthyroid goitre (author's transl)].
    Liebermeister H; Sobh J
    Dtsch Med Wochenschr; 1980 May; 105(22):792-4. PubMed ID: 7408650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aetiological treatment of benign goitre with l-thyroxine (author's transl)].
    Schmidt KJ; Rothenbuchner G; Reiser HH; Diehl K; Schuster H; Herzberg U
    Dtsch Med Wochenschr; 1980 Jul; 105(29):1015-8. PubMed ID: 7408700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of the thyroid gland after subtotal resection for hyperthyroidism in relation to remnant size.
    Gillquist J; Lundström B; Kågedal B
    Acta Chir Scand; 1977; 143(2):95-9. PubMed ID: 409016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.